A meta-analysis found a strong association between higher TyG index levels and increased risk of cognitive decline, particularly in younger adults, men, and Asian populations, suggesting its potential as a useful marker for cognitive health monitoring.
Older individuals with higher triglyceride levels, a common type of fat in the blood, may experience a decreased risk of dementia and a reduced rate of cognitive decline compared to those with lower levels, according to recent research. While the study, recently published in Neurology, the medical j
One in three #SouthAsians with #ASCVD on statins are eligible for icosapent ethyl (IPE). IPE should be considered for this high-risk population.
Story I wrote for the #MedicalPost. (Sorry, password protected for #doctors and #pharmacists).
Highlights:
A third of South Asians in Canada with known atherosclerotic #cardiovascular disease (ASCVD) and who take #statins would qualify to get additional treatment with icosapent ethyl (IPE).
This is a significant-sized population who could benefit from the additional lowering of triglycerides using IPE, according to a study presented at the recent annual meeting of the Canadian Cardiovascular Society (#CCS). This yearβs CCS had 1,400 in-person delegates, over 350 online delegates and 130 sessions.
However, a major study, the REDUCE-IT trial driving the use of IPE had very few non-white participants, according to a poster abstract presented by Canadian researchers.
IPE is a highly purified preparation of #eicosapentaenoic acid (EPA), which is an omega-3 fatty acid. It is used to treat severe hypertriglyceridemia (500 mg/dL and over). It is used as an adjunct to statin therapy to reduce the risk of cardiovascular events in people whose serum #triglyceride levels are over 150 mg/dL.
#MedMastodon